1 citations · 1 across the 3 of their papers we have counts for
1 paper · 1 filter
Marc Ditzhaus, Menggang Yu, Jin Xu
Recent observations, especially in cancer immunotherapy clinical trials with time-to-event outcomes, show that the commonly used proportial hazard assumption is often not justifiab…